AVITA Medical Inc

NASDAQ:RCEL   3:59:44 PM EDT
27.27
+0.26 (+0.96%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.93B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$6.06 Million
Adjusted EPS-$0.41
See more estimates
10-Day MA$23.70
50-Day MA$20.91
200-Day MA$18.42
See more pivots

Avita Therapeutics, Inc. Stock, NASDAQ:RCEL

28159 AVENUE STANFORD, SUITE 220, VALENCIA, CA 91355
United States of America
Phone: 661-367-9170
Number of Employees:

Description

Avita Medical Limited operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa. The company is based in Valencia, California.